Summary
Mediterranean spotted fever is a tick-borne disease that is endemic in the Mediterranean basin from spring to autumn. Usually mild, the disease can be severe in some cases, especially when risk factors are encountered in patients or when treatment is delayed. The correlation between these malignant forms and patients' immunological disorders remains unclear, while the pathophysiology of the disease seems well known. A case of a malignant form of Mediterranean spotted fever is reported which occurred 2 months prior to the diagnosis of polymyalgia rheumatica. Evidence of immunological disorders consisted only in an antiphospholipid antibody associated with a transient lupus anticoagulant. No underlying risk factors other than the primary undiagnosed phase of polymyalgia rheumatica has been observed.
Similar content being viewed by others
References
Raoult, D., Walker, D. H. Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers). In:Mandell, G. L., Douglas, R. G. Jr., Bennett, J. E., (eds.): Principles and practice of infectious diseases. 4th ed. Churchill Livingstone, New York 1995, pp. 1721–1727.
Fontcreus, B., Bella-Cueto, F., Espejo-Arenas, E., Vidal-Sanahuja, R., Muñoz-Espin, T., Nolla-Salas, M., Casagran-Borrell, A., Mercade-Cuesta, J., Segura-Porta, F. Mediterranean spotted fever. A cooperative study of 227 cases. Rev. Infect. Dis. 7 (1985) 635–642.
Raoult, D., Weiller, P. J., Chagnon, A., Chaudet, H., Gallais, H., Casanova, P. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am. J. Trop. Med. Hyg. 35 (1986) 845–850.
Raoult, D., Zuchelli, P., Weiller, P. J., Charrel, C., San Marco, J. L., Gallais, H., Casanova, P. Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983–1984. J. Infect. 12 (1986) 111–116.
Raoult, D., Kohler, J. L., Gallais, H., De Micco, Ph., Rousseau, S., Casanova, P. Rickettsiose mortelle. Nouv. Presse Méd. 11 (1982) 607.
Raoult, D., Gallais, H., Ottomani, A., Resch, J.P., Tichadou, D., De Micco, Ph., Casanova, P. La forme maligne de la fièvre boutonneuse méditerranéenne: six observations. Presse Méd. 12 (1983) 2375–2378.
Pallot, J. L., Voisin, S., Chauveau, P., Fadel, N., Kleinknecht, D., Mariel, C. La forme maligne de la fièvre boutonneuse méditerranéenne. Presse méd. 13 (1984) 1398.
Houvenaeghel, M., Ottomani, A., Raoult, D., Rouzaud, M., Manelli, J. C., Bimar, J. Une forme grave de fièvre boutonneuse méditerranéenne. Ann. Fr. Anesth. Réanim. 3 (1984) 134–136.
Almirall, J., Torremorell, D., Andreu, X., Font, B. Acute renal failure as a complication of Mediterranean spotted fever. Nephron 69 (1995) 338–339.
Brouqui, P., Rousseau, M. C., Drancourt, M., Raoult, D. Traitement des rickettsioses éruptives. Revue de la littérature de la microbiologie à la clinique. Bull. Soc. Pathol. Exot. 86 (1993) 336–341.
Meloni, T., Forteleoni, G. Glucose-6-phosphate dehydrogenase deficiency and Mediterranean fever in northern Sardinia. J. Infect. Dis. 146 (1982) 301.
Piras, M. A., Calia, G., Saba, F., Gakis, C., Andreoni, G. Glucose-6-phosphate dehydrogenase deficiency in male patients with Mediterranean spotted fever in Sardinia. J. Infect. Dis. 147 (1983) 607–608.
Raoult, D., Perrimont, H., Lena, D., Gallais, H., Walker, D. H., Casanova, P. Haemolysis with Mediterranean spotted fever and glucose-6-phosphate dehydrogenase deficiency. Trans. Roy. Soc. Trop. Med. Hyg. 80 (1986) 961–962.
Walker, D. H., Mattern, W. D. Rickettsial vasculitis. Am. Heart. J. 100 (1980) 896–906.
Ruiz, R., Herrero, I., Martin, A. M., Sanz, F., Mateos, A., Hernandez, A., Querol, R., Portugal, J. Vascular permeability in Boutonneuse fever. J. Infect. Dis. 149 (1984) 1036.
Ben Hamed, S., Kammoun, S., Kanoun, F., Ben Jemaa, M., Maaloul, I. Les modifications électrocardiographiques au cours de la fièvre boutonneuse méditerranéenne. Méd. Mal. Inf. 26 (1996) 734–735.
Davi, G., Giammarresi, C., Vigneri, S., Ganci, A., Ferri, C., Di Francesco, L., Vitale, G., Mansueto, S. Demonstration ofRickettsia conorii-induced coagulative and platelet activationin vivo in patients with Mediterranean spotted fever. Thromb. Haemost. 74 (1995) 631–634.
Vaarala, O., Palasuo, T. Anticardiolipin response in acute infection. Clin. Immunol. Immunopathol. 41 (1986) 8–15.
Aragon, A., Ceron, A. Arthritis in Mediterranean spotted fever. An immune complex mediated synovitis. Br. J. Rheumatol. 32 (1993) 642–643.
Mediavilla-Garcia, J. D., Omar-Mohamed, M., Lopez-Gomez, M., Jimenez-Alonso, J. Transitory monoclonal gammopathy and disseminated intravascular coagulation in Mediterranean boutonneuse fever. Ann. Med. Interne 12 (1995) 311–312.
Gastaut, J. A., Gamby, Th., Blanc, A. P., Carcassonne, Y. Périartérite noueuse avec sérologie rickettsienne positive. Nouv. Presse Méd. 5 (1976) 639–640.
Guillevin, L., Godeau, P. Périartérite noueuse systémique. In:Kahn, M. F., Peltier, A. P., Meyer, O., Piette, J. C. Les maladies systémiques. 3è ed.: Flammarion Médicine-Sciences, Paris 1991, pp. 563–604.
Barrier, J. H., Genereau, T. Maladie de Horton et pseudo-polyarthrite rhizomélique. In:Godeau, P., Herson, S., Piette, J. C. Traité de Médecine. 3è ed. Flammarion Médecine-Sciences, Paris 1996, pp. 169–172.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chaumentin, G., Zénone, T., Bibollet, C. et al. Malignant boutonneuse fever and polymyalgia rheumatica: A coincidental association?. Infection 25, 320–322 (1997). https://doi.org/10.1007/BF01720411
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01720411